You have 9 free searches left this month | for more free features.

pharmacological cardioversion

Showing 1 - 25 of 3,477

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Atrial Fibrillation Paroxysmal Trial in Moscow (Pharmacological cardioversion with Amiodarone, Pharmacological cardioversion

Recruiting
  • Atrial Fibrillation Paroxysmal
  • Pharmacological cardioversion with Amiodarone
  • Pharmacological cardioversion with Refralon
  • Moscow, Russian Federation
    Federal State Budgetary Institution NATIONAL MEDICAL RESEARCH CE
Jul 5, 2022

Atrial Fibrillation Trial in Warsaw (Antazoline, Propafenone)

Recruiting
  • Atrial Fibrillation
  • Warsaw, Poland
    Postgraduate Medical School
Feb 12, 2023

Atrium; Fibrillation, Atrium; Flutter Trial in Moscow (Pharmacological cardioversion with Refralon)

Recruiting
  • Atrium; Fibrillation
  • Atrium; Flutter
  • Pharmacological cardioversion with Refralon
  • Moscow, Russian Federation
    Federal State Budgetary Institution NATIONAL MEDICAL RESEARCH CE
Jul 13, 2022

Paroxysmal Atrial Fibrillation Trial in Madrid (Vernakalant, Flecainide)

Recruiting
  • Paroxysmal Atrial Fibrillation
  • Madrid, Madrid/Madrid, Spain
    Hospital Clínico Universitario San Carlos
Aug 5, 2022

Atrial Fibrillation Trial in Netherlands (Rate control, Pharmacological or electrical cardioversion)

Recruiting
  • Atrial Fibrillation
  • Rate control
  • Pharmacological or electrical cardioversion
  • Maastricht, Limburg, Netherlands
  • +13 more
Dec 2, 2021

Atrial Fibrillation Trial in Netherlands (Pharmacological cardioversion - Flecainide, Electrical cardioversion, Metoprolol)

Completed
  • Atrial Fibrillation
  • Pharmacological cardioversion - Flecainide
  • +5 more
  • Amsterdam, Netherlands
  • +14 more
Jan 17, 2020

Refralon®, Concentrate for Solution for Intravenous Injection in

Recruiting
  • Paroxysmal Atrial Fibrillation
  • +2 more
  • Ufa, Bashkortostan Republic, Russian Federation
  • +31 more
Mar 6, 2023

Atrial Fibrillation Trial (Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor, Rhythm control and anticoagulation)

Not yet recruiting
  • Atrial Fibrillation
  • Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
  • Rhythm control and anticoagulation
  • (no location specified)
Aug 14, 2023

Stepwise Strategy for Modifying Atrial Fibrillation Substrate

Recruiting
  • Atrial Fibrillation
  • late gadolinium enhanced magnetic resonance imaging
  • Chongqing, Chongqing, China
    The Second Affiliated Hospital of Chongqing Medical University
Jul 26, 2022

Atrial Fibrillation, Atrial Flutter Trial in Canada (drug-shock vs shock only)

Completed
  • Atrial Fibrillation
  • Atrial Flutter
  • drug-shock vs shock only
  • Calgary, Alberta, Canada
  • +9 more
Jul 19, 2019

Atrial Fibrillation Trial in Denmark, Hungary (AP30663, Placebo)

Recruiting
  • Atrial Fibrillation
  • Aalborg, Denmark
  • +14 more
Jun 23, 2022

Atrial Fibrillation Trial in Indianapolis (Ondansetron 8mg, Placebo)

Not yet recruiting
  • Atrial Fibrillation
  • Ondansetron 8mg
  • Placebo
  • Indianapolis, Indiana
  • +2 more
Apr 25, 2023

Atrial Fibrillation Trial in Calgary (Amiodarone Hydrochloride, Placebo)

Recruiting
  • Atrial Fibrillation
  • Amiodarone Hydrochloride
  • Placebo
  • Calgary, Alberta, Canada
    University of Calgary
Feb 7, 2022

Atrial Fibrillation Trial in Germany, United States (HSY244, Placebo)

Recruiting
  • Atrial Fibrillation
  • Chicago, Illinois
  • +12 more
Dec 14, 2022

Atrial Fibrillation, Post-cardiac Surgery Trial (Vernakalant, Amiodarone)

Not yet recruiting
  • Atrial Fibrillation
  • Post-cardiac Surgery
  • (no location specified)
May 16, 2022

Atrial Fibrillation Trial in Hamburg (Re-PVI only, Re-PVI + substrate ablation)

Recruiting
  • Atrial Fibrillation
  • Re-PVI only
  • Re-PVI + substrate ablation
  • Hamburg, Germany
    Asklepios Klinik St. Georg
Aug 9, 2022

Atrial Fibrillation Trial in Madrid (Line Set Strategy, Conventional strategy)

Recruiting
  • Atrial Fibrillation
  • Line Set Strategy
  • Conventional strategy
  • Madrid, Spain
    Hospital Universitario 12 de Octubre
Apr 24, 2023

Paroxysmal Atrial Fibrillation Trial in Worldwide (Boston Scientific Cardiac Cryoablation System)

Active, not recruiting
  • Paroxysmal Atrial Fibrillation
  • Boston Scientific Cardiac Cryoablation System
  • Phoenix, Arizona
  • +43 more
Aug 23, 2022

Atrial Fibrillation, Diastolic Dysfunction, HFpEF - Heart Failure With Preserved Ejection Fraction Trial in Burlington (As

Recruiting
  • Atrial Fibrillation
  • +2 more
  • As needed pharmacological rate control with beta-blocker (metoprolol tartrate, metoprolol succinate) or calcium channel blocker (diltiazem, verapamil)
  • Burlington, Vermont
    University of Vermont Medical Center
Feb 28, 2023

Heart Valve Incompetence, Atrial Fibrillation, Persistent Trial in Milan, MIlan (Echocardiography, Proteomic analyses)

Recruiting
  • Heart Valve Incompetence
  • Atrial Fibrillation, Persistent
  • Echocardiography
  • Proteomic analyses
  • Milan, Select A State, Italy
  • +1 more
Feb 28, 2023

COVID-19 Pneumonia, Atrial Fibrillation Trial in Tanta (Dexmedetomidine sedation)

Not yet recruiting
  • COVID-19 Pneumonia
  • Atrial Fibrillation
  • Dexmedetomidine sedation
  • Tanta, ELgharbiaa, Egypt
    Tanta University Hospitals
Dec 22, 2021

Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Out of Range Hypertension Trial in Netherlands, Spain

Completed
  • Paroxysmal Atrial Fibrillation
  • +3 more
  • procedure
  • Zwolle, Overijssel, Netherlands
  • +7 more
Jul 8, 2022

Atrial Fibrillation Trial in Buffalo (Magnesium Sulfate, Placebo)

Completed
  • Atrial Fibrillation
  • Magnesium Sulfate
  • Placebo
  • Buffalo, New York
    State University of New York at Buffalo
Sep 29, 2020

Atrial Fibrillation Prior and Post Elective Cardioversion

Not yet recruiting
  • Atrial Fibrillation
  • ECG monitoring prior and after cardioversion
  • (no location specified)
Jun 29, 2023

Morbidity of Cardiac Rhythm Disorders in Patients Assisted by

Not yet recruiting
  • Cardiac Rhythm Disorder
  • Follow up by phone call
  • (no location specified)
Mar 27, 2023